Drugs tackling chronic myelogenous leukemia have completely transformed prognoses of patients over the last couple of decades, with most cases going into remission. But drug resistance can occur, leading to relapses. Targeting the lipids involved in regulating part of a leukemia stem cell's life span offers a potential second route to defeat the disease -- and solid tumorous cancers as well.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/09/200918104257.htm
No comments:
Post a Comment